Glycemic Control after Initiating Direct-Acting Antiviral Agents in Patients with Hepatitis C Virus and Type 2 Diabetes Mellitus Using the United States Integrated Healthcare System

OBJECTIVE: Hepatitis C virus (HCV) has an increased risk of Type 2 diabetes mellitus (T2DM). Prior studies found that the eradication of HCV with direct-acting antiviral (DAA) agents led to improved glycemic control in patients with T2DM. We aimed to identify the association between HCV eradication...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Alicia Halim, Sie, John, Chen, Angela, Gunawan, Basuki, Chung, Joanie, Rashid, Nazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235457/
https://www.ncbi.nlm.nih.gov/pubmed/32489956
http://dx.doi.org/10.4103/jrpp.JRPP_19_110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235457/
https://www.ncbi.nlm.nih.gov/pubmed/32489956
http://dx.doi.org/10.4103/jrpp.JRPP_19_110

Ejemplares similares